SCHEMBL23764686

SCHEMBL23764686

CC(O)OCOC(O)C(C)N1C(=O)C(=O)c2cc(F)ccc21

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 4/20 0.45
CHRM5 P08912 2/20 0.37
TRPA1 O75762 1/20 0.37
NSD2 O96028 1/20 0.36
ALDH1A1 P00352 6/20 0.35
ALDH3A1 P30838 4/20 0.35
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA12 O43570 2/20 0.31
CA9 Q16790 2/20 0.31
CASP3 P42574 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23764705 0.90 PARK7 (0.42) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764615 0.86 PARK7 (0.42) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764650 0.86 PARK7 (0.41) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764711 0.83 CHRM5 (0.47) CHRM5
SCHEMBL23764644 0.82 PARK7 (0.43) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764660 0.81 PARK7 (0.51) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764761 0.80 PARK7 (0.41) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764619 0.79 PARK7 (0.43) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764688 0.79 PARK7 (0.54) PARK7CHRM5TRPA1NSD2ALDH1A1
SCHEMBL23764669 0.77 PARK7 (0.40) PARK7CHRM5TRPA1NSD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021162650-A1 5-FLUORO/5-TRIFLUOROMETHOXY-1H-INDOLE-2,3-DIONE 3-(4-PHENYLTHIOSEMICARBAZONE) DERIVATIVES AS INTERLEUKIN 1 (IL-1) ANTAGONISTS AND ANTI-PYRETIC AND/OR ANTI-INFLAMMATORY AGENTS FOR USE IN TREATING E.G. BEHÇET'S DISEASE ISTANBUL UNIVERSITESI (TR) 2021-08-19 WO disclosed